Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies
A Phase Ib, Open-label Study of Alpelisib (BYL719) in Combination With Cisplatin in Patients With HPV+ Solid Tumor Malignancies
Sponsor: Pamela Munster
Terminated
Funding
Other terminated trials from Pamela Munster
More terminations from Pamela Munster
This PHASE1 trial investigates Solid Tumors and is currently terminated or withdrawn. Pamela Munster leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Jun 2018 — Feb 2020 [monthly]
Recruiting PHASE1
▶ Show 4 earlier versions
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1
-
Jun 2017 — May 2018 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pamela Munster
For direct contact, visit the study record on ClinicalTrials.gov .